BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11737266)

  • 1. Transgenic over-expression of MafK suppresses T cell proliferation and function in vivo.
    Yoh K; Sugawara T; Motohashi H; Takahama Y; Koyama A; Yamamoto M; Takahashi S
    Genes Cells; 2001 Dec; 6(12):1055-66. PubMed ID: 11737266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity and expression of murine small Maf family protein MafK.
    Igarashi K; Itoh K; Motohashi H; Hayashi N; Matuzaki Y; Nakauchi H; Nishizawa M; Yamamoto M
    J Biol Chem; 1995 Mar; 270(13):7615-24. PubMed ID: 7706310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesodermal- vs. neuronal-specific expression of MafK is elicited by different promoters.
    Motohashi H; Igarashi K; Onodera K; Takahashi S; Ohtani H; Nakafuku M; Nishizawa M; Engel JD; Yamamoto M
    Genes Cells; 1996 Feb; 1(2):223-38. PubMed ID: 9140066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A core region of the mafK gene IN promoter directs neurone-specific transcription in vivo.
    Motohashi H; Ohta J; Engel JD; Yamamoto M
    Genes Cells; 1998 Oct; 3(10):671-84. PubMed ID: 9893024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive or negative MARE-dependent transcriptional regulation is determined by the abundance of small Maf proteins.
    Motohashi H; Katsuoka F; Shavit JA; Engel JD; Yamamoto M
    Cell; 2000 Dec; 103(6):865-75. PubMed ID: 11136972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced basal AP-1 activity and de-regulation of numerous genes in T cells transgenic for a dominant interfering mutant of FADD/MORT1.
    Chaneva S; Schneider G; Siegmund D; Wajant H; Mages J; Häcker G
    Eur J Immunol; 2004 Nov; 34(11):3006-15. PubMed ID: 15376191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two new members of the maf oncogene family, mafK and mafF, encode nuclear b-Zip proteins lacking putative trans-activator domain.
    Fujiwara KT; Kataoka K; Nishizawa M
    Oncogene; 1993 Sep; 8(9):2371-80. PubMed ID: 8361754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perinatal synthetic lethality and hematopoietic defects in compound mafG::mafK mutant mice.
    Onodera K; Shavit JA; Motohashi H; Yamamoto M; Engel JD
    EMBO J; 2000 Mar; 19(6):1335-45. PubMed ID: 10716933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MafK overexpression in pancreatic beta-cells caused impairment of glucose-stimulated insulin secretion.
    Shimohata H; Yoh K; Morito N; Shimano H; Kudo T; Takahashi S
    Biochem Biophys Res Commun; 2006 Aug; 346(3):671-80. PubMed ID: 16780794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Maf compound mutants display central nervous system neuronal degeneration, aberrant transcription, and Bach protein mislocalization coincident with myoclonus and abnormal startle response.
    Katsuoka F; Motohashi H; Tamagawa Y; Kure S; Igarashi K; Engel JD; Yamamoto M
    Mol Cell Biol; 2003 Feb; 23(4):1163-74. PubMed ID: 12556477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human small Maf proteins form heterodimers with CNC family transcription factors and recognize the NF-E2 motif.
    Toki T; Itoh J; Kitazawa J; Arai K; Hatakeyama K; Akasaka J; Igarashi K; Nomura N; Yokoyama M; Yamamoto M; Ito E
    Oncogene; 1997 Apr; 14(16):1901-10. PubMed ID: 9150357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of IL-2 and IL-4 gene expression by nodularin through the reduced NF-AT binding activity.
    Yea SS; Kim HM; Jeon YJ; Oh HM; Jeong HG; Yang KH
    Toxicol Lett; 2000 Apr; 114(1-3):215-24. PubMed ID: 10713487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive effect of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through the inhibition of T-lymphocyte proliferation and IL-2 production.
    Yun CH; Son CG; Jung U; Han SH
    Toxicology; 2006 Jan; 217(1):31-8. PubMed ID: 16168555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Bach2 as a B-cell-specific partner for small maf proteins that negatively regulate the immunoglobulin heavy chain gene 3' enhancer.
    Muto A; Hoshino H; Madisen L; Yanai N; Obinata M; Karasuyama H; Hayashi N; Nakauchi H; Yamamoto M; Groudine M; Igarashi K
    EMBO J; 1998 Oct; 17(19):5734-43. PubMed ID: 9755173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transactivation activity of Maf nuclear oncoprotein is modulated by Jun, Fos and small Maf proteins.
    Kataoka K; Noda M; Nishizawa M
    Oncogene; 1996 Jan; 12(1):53-62. PubMed ID: 8552399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One enhancer mediates mafK transcriptional activation in both hematopoietic and cardiac muscle cells.
    Katsuoka F; Motohashi H; Onodera K; Suwabe N; Engel JD; Yamamoto M
    EMBO J; 2000 Jun; 19(12):2980-91. PubMed ID: 10856242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The basic region and leucine zipper transcription factor MafK is a new nerve growth factor-responsive immediate early gene that regulates neurite outgrowth.
    Töröcsik B; Angelastro JM; Greene LA
    J Neurosci; 2002 Oct; 22(20):8971-80. PubMed ID: 12388604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and chromosome mapping of the human small maf-genes MAFG and MAFK.
    Iwata T; Kogame K; Toki T; Yokoyama M; Yamamoto M; Ito E
    Cytogenet Cell Genet; 1998; 82(1-2):88-90. PubMed ID: 9763667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The world according to Maf.
    Motohashi H; Shavit JA; Igarashi K; Yamamoto M; Engel JD
    Nucleic Acids Res; 1997 Aug; 25(15):2953-59. PubMed ID: 9224592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential induction of mafF, mafG and mafK expression by electrophile-response-element activators.
    Moran JA; Dahl EL; Mulcahy RT
    Biochem J; 2002 Jan; 361(Pt 2):371-7. PubMed ID: 11772409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.